Study Reveals Autoantibodies’ Role in Susceptibility to Viral Infections

A groundbreaking study from the University of Zurich reveals that about 2% of the population develops autoantibodies against type 1 interferons, heightening the risk of severe viral infections like COVID-19. These autoantibodies impair the immune response, making individuals more susceptible to viral diseases. The research emphasizes the need for further exploration into immune system complexities and potential therapeutic strategies to enhance defenses against viral infections.